Kinase Inhibitors For Cancer Treatment Market

The kinase inhibitors for cancer treatment market is projected to grow from USD 60.7 billion in 2025 to USD 164.8 billion by 2035, at a CAGR of 10.5%. EGFR inhibitors will dominate with a 32.5% market share, while hospitals will lead the end user segment with a 64.7% share.